Table of Contents

2019-2024 Global Clinical Next-Generation Sequencing Market Report (Status and Outlook)

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Clinical Next-Generation Sequencing Market Size 2014-2024
  • 2.1.2 Clinical Next-Generation Sequencing Market Size CAGR by Region
• 2.2 Clinical Next-Generation Sequencing Segment by Type
  • 2.2.1 Targeted Sequencing
  • 2.2.2 Exome Sequencing
  • 2.2.3 Others
• 2.3 Clinical Next-Generation Sequencing Market Size by Type
  • 2.3.1 Global Clinical Next-Generation Sequencing Market Size Market Share by Type (2014-2019)
  • 2.3.2 Global Clinical Next-Generation Sequencing Market Size Growth Rate by Type (2014-2019)
• 2.4 Clinical Next-Generation Sequencing Segment by Application
  • 2.4.1 Hospitals and Clinics
  • 2.4.2 Biopharma Companies
  • 2.4.3 Academic and Research Organizations
  • 2.4.4 Others
• 2.5 Clinical Next-Generation Sequencing Market Size by Application
  • 2.5.1 Global Clinical Next-Generation Sequencing Market Size Market Share by Application (2014-2019)
  • 2.5.2 Global Clinical Next-Generation Sequencing Market Size Growth Rate by Application (2014-2019)

3 Global Clinical Next-Generation Sequencing by Players

• 3.1 Global Clinical Next-Generation Sequencing Market Size Market Share by Players
  • 3.1.1 Global Clinical Next-Generation Sequencing Market Size by Players (2017-2019)
  • 3.1.2 Global Clinical Next-Generation Sequencing Market Size Market Share by Players (2017-2019)
• 3.2 Global Clinical Next-Generation Sequencing Key Players Head office and Products Offered
• 3.3 Market Concentration Rate Analysis
  • 3.3.1 Competition Landscape Analysis
  • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.4 New Products and Potential Entrants
• 3.5 Mergers & Acquisitions, Expansion

4 Clinical Next-Generation Sequencing by Regions

• 4.1 Clinical Next-Generation Sequencing Market Size by Regions
• 4.2 Americas Clinical Next-Generation Sequencing Market Size Growth
• 4.3 APAC Clinical Next-Generation Sequencing Market Size Growth
• 4.4 Europe Clinical Next-Generation Sequencing Market Size Growth
• 4.5 Middle East & Africa Clinical Next-Generation Sequencing Market Size Growth

5 Americas

• 5.1 Americas Clinical Next-Generation Sequencing Market Size by Countries
• 5.2 Americas Clinical Next-Generation Sequencing Market Size by Type
• 5.3 Americas Clinical Next-Generation Sequencing Market Size by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Clinical Next-Generation Sequencing Market Size by Countries
• 6.2 APAC Clinical Next-Generation Sequencing Market Size by Type
• 6.3 APAC Clinical Next-Generation Sequencing Market Size by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Clinical Next-Generation Sequencing by Countries
• 7.2 Europe Clinical Next-Generation Sequencing Market Size by Type
• 7.3 Europe Clinical Next-Generation Sequencing Market Size by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Clinical Next-Generation Sequencing by Countries
• 8.2 Middle East & Africa Clinical Next-Generation Sequencing Market Size by Type
• 8.3 Middle East & Africa Clinical Next-Generation Sequencing Market Size by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Global Clinical Next-Generation Sequencing Market Forecast

• 10.1 Global Clinical Next-Generation Sequencing Market Size Forecast (2019-2024)
• 10.2 Global Clinical Next-Generation Sequencing Forecast by Regions
  • 10.2.1 Global Clinical Next-Generation Sequencing Forecast by Regions (2019-2024)
  • 10.2.2 Americas Market Forecast
  • 10.2.3 APAC Market Forecast
  • 10.2.4 Europe Market Forecast
  • 10.2.5 Middle East & Africa Market Forecast
• 10.3 Americas Forecast by Countries
  • 10.3.1 United States Market Forecast
  • 10.3.2 Canada Market Forecast
  • 10.3.3 Mexico Market Forecast
  • 10.3.4 Brazil Market Forecast
• 10.4 APAC Forecast by Countries
  • 10.4.1 China Market Forecast
  • 10.4.2 Japan Market Forecast
  • 10.4.3 Korea Market Forecast
  • 10.4.4 Southeast Asia Market Forecast
  • 10.4.5 India Market Forecast
  • 10.4.6 Australia Market Forecast
• 10.5 Europe Forecast by Countries
  • 10.5.1 Germany Market Forecast
  • 10.5.2 France Market Forecast
  • 10.5.3 UK Market Forecast
  • 10.5.4 Italy Market Forecast
  • 10.5.5 Russia Market Forecast
  • 10.5.6 Spain Market Forecast
• 10.6 Middle East & Africa Forecast by Countries
  • 10.6.1 Egypt Market Forecast
  • 10.6.2 South Africa Market Forecast
  • 10.6.3 Israel Market Forecast
  • 10.6.4 Turkey Market Forecast
  • 10.6.5 GCC Countries Market Forecast
• 10.7 Global Clinical Next-Generation Sequencing Forecast by Type
• 10.8 Global Clinical Next-Generation Sequencing Forecast by Application

11 Key Players Analysis

• 11.1 Thermo Fisher Scientific
  • 11.1.1 Company Details
  • 11.1.2 Clinical Next-Generation Sequencing Product Offered
  • 11.1.3 Thermo Fisher Scientific Clinical Next-Generation Sequencing Revenue, Gross Margin and Market Share (2017-2019)
  • 11.1.4 Main Business Overview
  • 11.1.5 Thermo Fisher Scientific News
• 11.2 PerkinElmer
  • 11.2.1 Company Details
  • 11.2.2 Clinical Next-Generation Sequencing Product Offered
  • 11.2.3 PerkinElmer Clinical Next-Generation Sequencing Revenue, Gross Margin and Market Share (2017-2019)
  • 11.2.4 Main Business Overview
  • 11.2.5 PerkinElmer News
• 11.3 Illumina
  • 11.3.1 Company Details
  • 11.3.2 Clinical Next-Generation Sequencing Product Offered
  • 11.3.3 Illumina Clinical Next-Generation Sequencing Revenue, Gross Margin and Market Share (2017-2019)
  • 11.3.4 Main Business Overview
  • 11.3.5 Illumina News
• 11.4 Beckman Coulter
  • 11.4.1 Company Details
  • 11.4.2 Clinical Next-Generation Sequencing Product Offered
  • 11.4.3 Beckman Coulter Clinical Next-Generation Sequencing Revenue, Gross Margin and Market Share (2017-2019)
  • 11.4.4 Main Business Overview
  • 11.4.5 Beckman Coulter News
• 11.5 GATC Biotech
  • 11.5.1 Company Details
  • 11.5.2 Clinical Next-Generation Sequencing Product Offered
  • 11.5.3 GATC Biotech Clinical Next-Generation Sequencing Revenue, Gross Margin and Market Share (2017-2019)
  • 11.5.4 Main Business Overview
  • 11.5.5 GATC Biotech News
• 11.6 Qiagen
  • 11.6.1 Company Details
  • 11.6.2 Clinical Next-Generation Sequencing Product Offered
  • 11.6.3 Qiagen Clinical Next-Generation Sequencing Revenue, Gross Margin and Market Share (2017-2019)
  • 11.6.4 Main Business Overview
  • 11.6.5 Qiagen News

...

12 Research Findings and Conclusion

Next-generation sequencing (NGS) has been rapidly integrated into molecular pathology, dramatically increasing the breadth genomic of information available to oncologists and their patientseration sequencing.

According to this study, over the next five years the Clinical Next-Generation Sequencing market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Clinical Next-Generation Sequencing business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Clinical Next-Generation Sequencing market by product type, application, key companies and key regions.

This study considers the Clinical Next-Generation Sequencing value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Targeted Sequencing
Exome Sequencing
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospitals and Clinics
Biopharma Companies
Academic and Research Organizations
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Thermo Fisher Scientific
PerkinElmer
Illumina
Beckman Coulter
GATC Biotech
Qiagen
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Clinical Next-Generation Sequencing market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Clinical Next-Generation Sequencing market by identifying its various subsegments.
Focuses on the key global Clinical Next-Generation Sequencing players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Clinical Next-Generation Sequencing with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Clinical Next-Generation Sequencing submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.